$TAK· SEC filing ·

TAK Outlines Executive Compensation Strategy, Ties Pay to Performance with 30% Relative TSR Modifier, Emphasizes Long-term Shareholder Value Creation

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · Now $15.96

+0.9% in 1d after detection

Post-detection moves

1h
+0.2%
1d
+0.9%
3d
-0.2%
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS